× Digital News Videos Health & Science Lifestyle Opinion Education Columnists Moi Cabinets Arts & Culture Fact Check Podcasts E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Health Magazine TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Jobs Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
menu search
Standard Logo
Home / Health & Science

WHO approves second Chinese Covid-19 vaccine for emergency use

HEALTH & SCIENCEBy ROSA AGUTU | Fri,Jun 04 2021 00:00:00 EAT
By ROSA AGUTU | Fri,Jun 04 2021 00:00:00 EAT

 A health worker prepares a dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine, during a mass vaccination program in Apodaca, on the outskirts of Monterrey, Mexico May 25, 2021. [Reuters, Daniel Becerril]

The World Health Organisation (WHO) has okayed a second Chinese vaccine for emergency use.

Sinovac-CoronaVac, a two-dose vaccine, got the nod after it met international standards for safety and efficacy.

It is already being used in several countries.

WHO said it prevents symptoms in 51 per cent of those vaccinated and has a 100 per cent efficacy on severe Covid-19 hospitalisation cases. 

The Emergency Use Listing (EUL) comes one month after WHO approved the first Chinese vaccine, Sinopharm, also for emergency use.

WHO Director-General Tedros Ghebreyesus on Wednesday said the vaccine’s easy storage contributed to its approval and inclusion in the Covax facility, for which Sinovac/China National Pharmaceutical Group has produced 10 million doses from a projected annual target of three billion doses by year’s end.

“Easy storage of CoronaVac makes it suitable for low resource settings,” Ghebreyesus explained.

It is now crucial to get these life-saving tools to the people that need them quickly,” he added.

CoronaVac comes at a time when the country is facing a shortage of vaccines, owing to a surge in Covid cases in India, which was supplying the bulk of AstraZeneca vaccines.

It's the eighth vaccine to receive EUL by WHO.

Related Topics

Share this story